Ann: Medlab Completes First Order of New Cannabinoid to UK, page-4

Dilution is never good. But after this raise would be equivalent to 50mill shares on offer at 90cents. for Nanabis phase 3 showing phase2 reduces chronic cancer pain by 40% is not a stab in the dark. And then there is phase2 depression trial which has a huge market that one. And then there is nanocelle platform that would work for any generic drug more efficient than tablets...